These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 35696319)

  • 21. K114 inhibits A-beta aggregation and inflammation in vitro and in vivo in AD/Tg mice.
    Zhang YH; Mann D; Raymick J; Sarkar S; Paule MG; Lahiri DK; Dumas M; Bell-Cohen A; Schmued LC
    Curr Alzheimer Res; 2014 Mar; 11(3):299-308. PubMed ID: 24552157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid β aggregation in Alzheimer's disease.
    Huo X; Zhang Y; Jin X; Li Y; Zhang L
    J Photochem Photobiol B; 2019 Jan; 190():98-102. PubMed ID: 30504054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotective effects of curcumin lipid-core nanocapsules in a model Alzheimer's disease induced by β-amyloid 1-42 peptide in aged female mice.
    Giacomeli R; Izoton JC; Dos Santos RB; Boeira SP; Jesse CR; Haas SE
    Brain Res; 2019 Oct; 1721():146325. PubMed ID: 31325424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology.
    Michno W; Nyström S; Wehrli P; Lashley T; Brinkmalm G; Guerard L; Syvänen S; Sehlin D; Kaya I; Brinet D; Nilsson KPR; Hammarström P; Blennow K; Zetterberg H; Hanrieder J
    J Biol Chem; 2019 Apr; 294(17):6719-6732. PubMed ID: 30814252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coassembled Chitosan-Hyaluronic Acid Nanoparticles as a Theranostic Agent Targeting Alzheimer's β-Amyloid.
    Wang W; Liu M; Gao W; Sun Y; Dong X
    ACS Appl Mater Interfaces; 2021 Dec; 13(47):55879-55889. PubMed ID: 34786930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel monoclonal antibody against the N-terminus of Aβ1-42 reduces plaques and improves cognition in a mouse model of Alzheimer's disease.
    Xing HY; Li B; Peng D; Wang CY; Wang GY; Li P; Le YY; Wang JM; Ye G; Chen JH
    PLoS One; 2017; 12(6):e0180076. PubMed ID: 28662102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of amyloid beta toxicity in zebrafish with a chaperone-gold nanoparticle dual strategy.
    Javed I; Peng G; Xing Y; Yu T; Zhao M; Kakinen A; Faridi A; Parish CL; Ding F; Davis TP; Ke PC; Lin S
    Nat Commun; 2019 Aug; 10(1):3780. PubMed ID: 31439844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain Targeting and Aβ Binding Bifunctional Nanoparticles Inhibit Amyloid Protein Aggregation in APP/PS1 Transgenic Mice.
    Zhang X; Zhang X; Li Y; Zhong M; Zhao P; Guo C; Xu H; Wang T; Gao H
    ACS Chem Neurosci; 2021 Jun; 12(12):2110-2121. PubMed ID: 34042421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo application of beta amyloid oligomers: a simple tool to evaluate mechanisms of action and new therapeutic approaches.
    Balducci C; Forloni G
    Curr Pharm Des; 2014; 20(15):2491-505. PubMed ID: 23859553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effect of Cannabidiol Coated by Nano-Chitosan on Learning and Memory, Hippocampal CB1 and CB2 Levels, and Amyloid Plaques in an Alzheimer's Disease Rat Model.
    Amini M; Abdolmaleki Z
    Neuropsychobiology; 2022; 81(3):171-183. PubMed ID: 34727550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythrocyte membrane-coated nanocarriers modified by TGN for Alzheimer's disease.
    Gu J; Yan C; Yin S; Wu H; Liu C; Xue A; Lei X; Zhang N; Geng F
    J Control Release; 2024 Feb; 366():448-459. PubMed ID: 38128884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microfluidic Synthesis of Ultrasmall Chitosan/Graphene Quantum Dots Particles for Intranasal Delivery in Alzheimer's Disease Treatment.
    Mohebichamkhorami F; Faizi M; Mahmoudifard M; Hajikarim-Hamedani A; Mohseni SS; Heidari A; Ghane Y; Khoramjouy M; Khayati M; Ghasemi R; Zali H; Hosseinzadeh S; Mostafavi E
    Small; 2023 Oct; 19(40):e2207626. PubMed ID: 37309299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is Alzheimer's disease a result of presynaptic failure? Synaptic dysfunctions induced by oligomeric beta-amyloid.
    Nimmrich V; Ebert U
    Rev Neurosci; 2009; 20(1):1-12. PubMed ID: 19526730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of amyloid plaques targeted by bifunctional USPIO in Alzheimer's disease transgenic mice using magnetic resonance microimaging.
    Wadghiri YZ; Li J; Wang J; Hoang DM; Sun Y; Xu H; Tsui W; Li Y; Boutajangout A; Wang A; de Leon M; Wisniewski T
    PLoS One; 2013; 8(2):e57097. PubMed ID: 23468919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antioxidative and Anti-inflammatory Effects of Kojic Acid in Aβ-Induced Mouse Model of Alzheimer's Disease.
    Khan A; Park TJ; Ikram M; Ahmad S; Ahmad R; Jo MG; Kim MO
    Mol Neurobiol; 2021 Oct; 58(10):5127-5140. PubMed ID: 34255249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chitosan oligosaccharides alleviate cognitive deficits in an amyloid-β1-42-induced rat model of Alzheimer's disease.
    Jia S; Lu Z; Gao Z; An J; Wu X; Li X; Dai X; Zheng Q; Sun Y
    Int J Biol Macromol; 2016 Feb; 83():416-25. PubMed ID: 26601759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multifunctional peptide rescues memory deficits in Alzheimer's disease transgenic mice by inhibiting Aβ42-induced cytotoxicity and increasing microglial phagocytosis.
    Xue D; Zhao M; Wang YJ; Wang L; Yang Y; Wang SW; Zhang R; Zhao Y; Liu RT
    Neurobiol Dis; 2012 Jun; 46(3):701-9. PubMed ID: 22426388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of Nanocomposites and Nanoparticles in Treating Neurodegenerative Disorders.
    Fatima J; Siddique YH
    CNS Neurol Disord Drug Targets; 2024; 23(10):1217-1233. PubMed ID: 38288843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.